glp-1 and kidney function Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney heart protection Glucagon-Like Peptide-1 Receptor Agonist Use

Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

(Graphic: Business Wire) Hims Hers has been collecting data on access challenges across GLP-1s since the beginning of September

Boost your digestion and GLP-1 production with GLP-1 Gummies

Learn how these peptide therapies support metabolic health and weight management at Revital Trichology & Wellness.

Long, unpredictable shifts meant going eight hours without a proper meal, then coming home utterly exhausted and eating whatever was in front of me